European Countries Suspend Use of AstraZeneca Vaccine Over Blood Clot Reports
Summary from the AllSides News Team
Featured Coverage of this Story
From the Left
AstraZeneca's COVID vaccine suspended in more countries over low number of blood clotsSweden on Tuesday became the latest to join a growing list of countries to suspend use of the Oxford-AstraZeneca coronavirus vaccine. More than a dozen nations, most of them in Europe, have temporarily halted use of the vaccine as a precautionary measure after a small number of people developed blood clots after getting the shot.
But experts in the U.K. and elsewhere in Europe are calling it a disaster for the continent's already-delayed vaccine roll-out. COVID-19 infections are spreading exponentially again in some parts of Europe, even prompting new nationwide...
From the Center
Germany, Italy, France suspend AstraZeneca shots amid safety fears, disrupting EU vaccinationsGermany, France and Italy said on Monday they would suspend AstraZeneca COVID-19 shots after several countries reported possible serious side-effects, but the World Health Organization (WHO) said there was no proven link and people should not panic.
Still, the decision by the European Union’s three biggest countries to put inoculations with the AstraZeneca shot on hold threw the already struggling vaccination campaign in the 27-nation EU into disarray.
Denmark and Norway stopped giving the shot last week after reporting isolated cases of bleeding, blood clots and a low platelet count....
From the Right
AstraZeneca tries to reassure public after recent COVID vaccine safety concernsAstraZeneca issued a statement on Monday defending its COVID-19 vaccine after some countries raised concerns about blood clots in vaccine recipients and called for a temporary suspension.
The company said there is "no evidence of an increased risk" of blood clots after receiving its jab.
Ireland announced Sunday that it would temporarily suspend distributing the vaccine "out of an abundance of caution," Reuters reported. The move was announced after reports of blood clotting in some of the recipients in Norway.
AllSides Picks
April 18th, 2024
April 18th, 2024
April 18th, 2024